Literature DB >> 3056001

Screening for Chlamydia trachomatis infection in a pregnancy counseling clinic.

B Binns1, T Williams, J McDowell, R C Brunham.   

Abstract

Five hundred twenty asymptomatic women attending a pregnancy counseling clinic were interviewed and screened for cervical Chlamydia trachomatis infection before therapeutic abortion. Overall, 56 (10.8%) women were culture positive for C. trachomatis. Restricting testing to women with risk factors for infection or who had cervical leukocytosis on Gram staining of cervical mucus, or who were seropositive for C. trachomatis antibodies proved impractical because of insensitivity or nonspecificity. We evaluated three chlamydia diagnostic tests to determine which test had the best performance characteristics. In comparison with culture, the direct fluorescent antigen test had a sensitivity of 89% and a positive predictive value of 78%, whereas the enzyme immunoassay had 96% and 69%, respectively. When analysis was redone with any two positive laboratory tests to define true infection status, the performance parameters of enzyme immunoassay were sensitivity 98%, specificity 98%, and positive predictive value 87%. We conclude that all women undergoing therapeutic abortion require testing for C. trachomatis infection and that enzyme immunoassay is the most effective and practical test in this group of women.

Entities:  

Keywords:  Americas; Biology; Canada; Cervical Effects; Cervix; Chlamydia; Demographic Factors; Developed Countries; Diseases; Evaluation; Examinations And Diagnoses; Genitalia; Genitalia, Female; Infections; Laboratory Examinations And Diagnoses; Laboratory Procedures; North America; Northern America; Physiology; Population; Population Characteristics; Pregnant Women; Reproductive Tract Infections; Research Report; Screening; Sexually Transmitted Diseases; Urogenital System; Uterus

Mesh:

Year:  1988        PMID: 3056001     DOI: 10.1016/0002-9378(88)90433-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Comparison of polymerase chain reaction and chlamydiazyme for the detection of Chlamydia trachomatis in clinical specimens.

Authors:  T W Williams; S D Tyler; S Giercke; D R Pollard; P McNicol; K R Rozee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

2.  Cervico-vaginal Chlamydia trachomatis infection in pregnant adolescent and adult women. A morphologic and immunofluorescent study.

Authors:  M J Cavaliere; M Y Maeda; N K Shirata; A Longatto Filho; L W Shih; M de Siqueira; M G de Muelenare Correa; H F Oliveira
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

3.  The association between Chlamydia cervicitis, chorioamnionitis and neonatal complications.

Authors:  G G Donders; P Moerman; G H De Wet; P Hooft; P Goubau
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

4.  [Prevalence of cervical Chlamydia trachomatis infection in a female population seeking contraception counseling].

Authors:  R Boisvert; A Côté; M Poulin; J Lefebvre
Journal:  CMAJ       Date:  1993-01-15       Impact factor: 8.262

5.  Using recombinant Chlamydia trachomatis OMP2 as antigen in diagnostic ELISA test.

Authors:  Mahdieh Javaherian; Zarin Sharifnia; Robabeh Taheripanah; Mojgan Bandepour; Mohammad Soleimani; Bahram Kazemi
Journal:  Iran J Microbiol       Date:  2014-02

6.  Prevalence of cervicovaginal infections during gestation and accuracy of clinical diagnosis.

Authors:  J A Simões; P C Giraldo; A Faúndes
Journal:  Infect Dis Obstet Gynecol       Date:  1998

7.  Performance of the syva direct fluorescent antibody assay for Chlamydia in a low-prevalence population.

Authors:  M B Reedy; P J Sulak; W B McCombs Iii; T J Kuehl
Journal:  Infect Dis Obstet Gynecol       Date:  1993
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.